William Dickey, MD
Otolaryngology · Parker, CONPI 1598722084
Payments from drug & device makers
Across 42 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$182
- Optinose US, Inc.$108
- AstraZeneca$92
- KARL Storz Endoscopy-america$87
- Aerin Medical Inc.$79
- Stryker$76
- plus $406 from 12 others
What the payments were for
- Food & beverage$91389%
- Education$293%
- Gifts$878%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 8 | $182 |
| Optinose US, Inc. | 5 | $108 |
| AstraZeneca | 4 | $92 |
| KARL Storz Endoscopy-america | 1 | $87 |
| Aerin Medical Inc. | 3 | $79 |
| Stryker | 3 | $76 |
| Intersect ENT, Inc. | 3 | $71 |
| Medtronic | 2 | $68 |
| Lucid Diagnostics Inc. | 1 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Novartis | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $29 |
| GSK | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Acclarent, Inc | 1 | $19 |
| Smith+Nephew | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
How this compares
$1,029 in reported general payments places this provider in the 50th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 15 | $885 |
| Cefdinir | 16 | $352 |
| Ipratropium Bromide | 13 | $233 |
| Amoxicillin | 16 | $74 |
| Prednisone | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Parker
- Garrick TalmageParker$3K
- Bryan DavisColorado Springs$1.4M
- Suzanne BertramFort Collins$475K
- Vijay RamakrishnanAurora$252K
- Barton KnoxColorado Springs$198K
- Nicholas BeckmannColorado Springs$158K
- Stephen CassAurora$78K
- Michael WilhelmColorado Springs$76K
- McKay MolineGrand Junction$71K
- Andrew WinklerAurora$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.